NHS: Drugs

(asked on 14th December 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the quality assurance and governance processes set out in contracts for homecare medicines service in England include as key performance indicators for monthly performance assessment the number of (a) delayed deliveries, (b) delayed treatment initiations and (c) missed doses.


Answered by
Will Quince Portrait
Will Quince
This question was answered on 20th December 2022

Homecare providers are assessed on a monthly basis against national Key Performance Indicators (KPIs) for National Health Service framework agreements and regionally for local contracting. Regular formal assessments are made through face-to-face meetings with the National Homecare Medicines Committee (NHMC) and NHS England. These KPIs include delayed deliveries and missed doses.

When KPIs or NHS hospitals report that service levels do not meet the relevant standards, the NHMC enacts an escalation process. Where this process is in place, the affected homecare provider will provide each NHS organisation with a summary of the issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed.

The National Clinical Homecare Association is working with the British Society for Rheumatology to arrange discussions with its members, the NHMC and NHS England regarding the safety and performance of the Homecare Medicine Delivery Service.

Reticulating Splines